Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 35
Lymphoma Drugs 29
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Allergy and Immunology 26
Enzymes 26
Respiratory Drugs 25
Oncology 22
Pulmonary Medicine 20
Central Nervous System Drugs 20
Drug Delivery 19
Infusions and Injectables 17
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Biomarkers 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Needles and Syringes 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



283 reviews

1,018 Results (Page 37 of 51)
- Relevance
  Sort by

Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type (Calicheamicin, MMAE), Target (HER2, CD30, CD22), Disease, and Region - Forecast to 2028

 Report
October 2023
273 Pages
Global

From

€4478EUR$4,950USD£3,835GBP

Diphtheria Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Aspergillosis Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Multidrug Resistant Bacteria Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Antiviral Combination Therapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Herpangina Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Systemic Aspergillosis and Systemic Candidiasis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Nucleic Acid-Based Drugs Market - Global Forecast 2026-2032

 Report
January 2026
183 Pages
Global

From

€3207EUR$3,545USD£2,746GBP

€3563EUR$3,939USD£3,052GBP

Remdesivir Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Invasive Fungal Infections Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Pseudomonas Aeruginosa Infection Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Investor Series: Opportunities in the Cell and Gene Therapy Market

 Report
April 2022
121 Pages
Global

From

€1718EUR$1,899USD£1,471GBP

PD-1 And PD-L1 Inhibitors - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
160 Pages
Global

From

€4297EUR$4,750USD£3,680GBP

Congenital Heart Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1809EUR$2,000USD£1,549GBP

Portal Hypertension - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1809EUR$2,000USD£1,549GBP

Global CD19 Antibody Market & Clinical Pipeline Outlook 2028

 Report
October 2023
420 Pages
Global

From

€2623EUR$2,900USD£2,247GBP

Herpangina Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
185 Pages
Global

From

€4071EUR$4,500USD£3,486GBP

Letermovir Drugs Market - Global Forecast 2025-2030

 Report
August 2025
198 Pages
Global

From

€3207EUR$3,545USD£2,746GBP

€3563EUR$3,939USD£3,052GBP

Oral Anti-HBV Drugs Market - Global Forecast 2025-2030

 Report
August 2025
182 Pages
Global

From

€3207EUR$3,545USD£2,746GBP

€3563EUR$3,939USD£3,052GBP

Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027

 Report
January 2022
292 Pages
Global

From

€3392EUR$3,750USD£2,905GBP

1,018 Results (Page 37 of 51)
- 1
- 35
- 36
- 37
- 38
- 39

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.